Medicare Enrolled
Dr. Said Ibrahimi, MD
Neurology · San Jose, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ibrahimi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ibrahimi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ibrahimi
Dr. Said Ibrahimi is a neurology specialist in San Jose, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ibrahimi performed 1,476 Medicare services across 1,262 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ibrahimi received a total of $14,809 from 57 pharmaceutical and/or device companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ibrahimi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 25% volume in CA
$14,809 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,476
Medicare services
Top 25% in CA for neurology
1,262
Unique beneficiaries
$179
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
284 | $112 | $1,150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
158 | $162 | $1,450 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
112 | $414 | $4,400 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
111 | $287 | $2,800 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
109 | $303 | $2,800 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
109 | $173 | $2,800 |
| New patient office visit, complex (60-74 min) | 98 | $189 | $2,750 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
73 | $101 | $1,200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $128 | $2,400 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
48 | $207 | $545 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
46 | $119 | $1,500 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
46 | $38 | $450 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $81 | $750 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
26 | $40 | $350 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
26 | $108 | $975 |
| Use of electrodes during balance testing Application of electrodes to monitor physiological responses during a balance assessment. |
26 | $12 | $100 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
25 | $243 | $3,000 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
23 | $139 | $1,200 |
| Needle electromyography of trunk or head muscles A test that uses a needle electrode to measure the electrical activity of muscles in the trunk or head. This helps evaluate muscle and nerve function. |
20 | $87 | $700 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $209 | $2,800 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
15 | $39 | $450 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
13 | $290 | $2,504 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,809
Total received (2018-2024)
Avg $2,116/year across 7 years
Top 19% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
698
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,796 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,183
2023
$3,920
2022
$2,975
2021
$2,686
2020
$912
2019
$703
2018
$429
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$487
UCB, Inc.
$327
PFIZER INC.
$310
Neurelis, Inc.
$307
ABBVIE INC.
$262
CATALYST PHARMACEUTICALS, INC.
$186
Eisai Inc.
$160
Acorda Therapeutics, Inc
$153
Neurocrine Biosciences, Inc.
$130
SK Life Science, Inc.
$125
Sumitomo Pharma America, Inc.
$86
Otsuka America Pharmaceutical, Inc.
$81
Biogen, Inc.
$77
Teva Pharmaceuticals USA, Inc.
$70
MITSUBISHI TANABE PHARMA AMERICA, INC.
$63
Octapharma USA, Inc.
$60
Kyowa Kirin, Inc.
$56
Aucta Pharmaceuticals, Inc.
$53
GE HEALTHCARE
$41
Merz Pharmaceuticals, LLC
$36
Indivior Inc.
$35
Axsome Therapeutics, Inc.
$29
Corium, LLC
$28
Janssen Pharmaceuticals, Inc
$23
Top 3 companies account for 35.3% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,402
Biogen, Inc.
$1,093
UCB, Inc.
$1,025
Teva Pharmaceuticals USA, Inc.
$1,006
ABBVIE INC.
$821
SK Life Science, Inc.
$795
Acorda Therapeutics, Inc
$753
Sumitomo Pharma America, Inc.
$688
Sunovion Pharmaceuticals Inc.
$610
Neurelis, Inc.
$516
PFIZER INC.
$495
AbbVie Inc.
$464
Eisai Inc.
$446
Allergan, Inc.
$393
Janssen Pharmaceuticals, Inc
$381
Kyowa Kirin, Inc.
$329
Otsuka America Pharmaceutical, Inc.
$323
Allergan Inc.
$316
Alexion Pharmaceuticals, Inc.
$216
Biohaven Pharmaceutical Holding Company Ltd.
$210
Biohaven Pharmaceuticals, Inc.
$194
CATALYST PHARMACEUTICALS, INC.
$186
Abbott Laboratories
$174
Axsome Therapeutics, Inc.
$146
Octapharma USA, Inc.
$142
Neurocrine Biosciences, Inc.
$130
ITI, Inc.
$124
IMPEL PHARMACEUTICALS INC.
$104
MITSUBISHI TANABE PHARMA AMERICA, INC.
$99
GE HealthCare
$99
Lundbeck LLC
$93
Merz Pharmaceuticals, LLC
$86
Alnylam Pharmaceuticals Inc.
$74
GE HEALTHCARE
$67
Currax Pharmaceuticals LLC
$67
Novartis Pharmaceuticals Corporation
$64
Dynasplint Systems Inc.
$57
Amgen Inc.
$53
Aucta Pharmaceuticals, Inc.
$53
GRT US Holding, Inc.
$51
Amneal Pharmaceuticals LLC
$49
Takeda Pharmaceuticals U.S.A., Inc.
$49
Avanir Pharmaceuticals, Inc.
$37
Indivior Inc.
$35
EISAI INC.
$35
Ipsen Biopharmaceuticals, Inc
$32
Averitas Pharma Inc.
$31
Corium, LLC
$28
Medtronic, Inc.
$25
Banner Life Sciences, LLC
$24
Alfasigma USA, Inc.
$23
Grifols USA, LLC
$21
IDORSIA PHARMACEUTICALS US INC
$17
Adamas Pharmaceuticals, Inc.
$16
PORTOLA PHARMACEUTICALS, LLC
$16
AbbVie, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$13
Top 3 companies account for 23.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADUHELM · AJOVY · AMYVID · ANDEXXA · APTIOM · AUSTEDO · AVONEX · Aimovig · Austedo XR · Auvelity · Azstarys · BAFIERTAM · BOTOX · Banzel · Briviact · CAPLYTA · COMIRNATY · CONFIRM RX · DUOPA · Duopa · Dynasplint · Dysport · EMGALITY · FYCOMPA · Fycompa · GEMTESA · GOCOVRI · Gamunex-C · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LINQ II · Leqembi · MOUNJARO · Motpoly XR · NOURIANZ · NUEDEXTA · NURTEC ODT · Nourianz · Nuedexta · ONPATTRO · ONZETRA XSAIL · PANZYGA · PAXLOVID · Ponvory · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · REYVOW · RYTARY · SOLIRIS · SPRAVATO · SUBLOCADE · Soliris · TECFIDERA · TRINTELLIX · TRULICITY · TYSABRI · Trudhesa · UBRELVY · UZEDY · VALTOCO · VIIBRYD · VRAYLAR · VYEPTI · XCOPRI · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
224
Per 100K population
11.8
County median income
$159,674
Nearest hospital
REGIONAL MEDICAL CENTER OF SAN JOSE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ibrahimi is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ibrahimi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ibrahimi performed 284 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ibrahimi receive payments from pharmaceutical companies?
Yes. Dr. Ibrahimi received a total of $14,809 from 57 companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ibrahimi's costs compare to other neurologists in San Jose?
Dr. Ibrahimi's average Medicare payment per service is $179. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ibrahimi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in San Jose
Browse neurologists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology